RELEASE DATE:  April 5, 2004

NOTICE:  NOT-CA-04-011   

National Cancer Institute (NCI)

The National Cancer Institute is requesting applications for 
administrative supplements for NCI-funded cancer control intervention 
research RO1, P01, P50, U01, and U19 grants.  Applicants may apply for 
a supplement to a related R01, P01, P50, U01, or U19 intervention 
research award, as long as the following conditions are met: 
1) The focus of the awarded grant is similar to the focus of the 
intervention dissemination supplement that is being proposed, 
2) There are no funds in the related award related to the proposed 
dissemination effort.  
3) There must be an active parent grant during the entire funding 
period of this supplement.  
4) The Principal Investigator for the supplement must be the Principal 
Investigator of the parent grant.

These supplements have been designed to provide 1-year funding to 
cancer control investigators whose intervention efficacy data have been 
analyzed and who are conducting peer-reviewed research (with an active 
NCI grant award) related to the intervention program proposed for 
dissemination.   Intervention research across the cancer control 
continuum that may be eligible for these supplements, includes: tobacco 
use prevention and cessation; promotion of appropriate changes in diet 
and physical activity; reduction of sun exposure and ultraviolet (UV) 
radiation exposure; facilitation of informed decisions about genetic 
testing for cancer susceptibility; enhancement of screening for breast, 
cervix and colorectal cancers; quality of care; and improvements in 
coping skills and quality-of-life for cancer survivors and their 

Detailed instructions for applying for this supplement will be posted 
at April 7, 2004.  
The receipt date for applications is June 30, 2004.

The application should take the form of a request letter that contains 
sufficient detail to allow assessment of the scientific merit of the 
proposed dissemination plans and the appropriateness of the request for 
supplemental funding (see web site for more detailed application 
information).  Budgets should not exceed $125,000 in direct costs for a 
time period not exceeding 12 months.  All requests require an itemized 
budget and must be countersigned by the grantee institution’s business 
office.  Requests for supplements under this program must comply with 
NIH policies for inclusion of women, minorities, and children in 
research involving human subjects.

Request letters will be evaluated by NCI program staff (and appropriate 
consultants) who have expertise in the cancer control intervention area 
and/or in dissemination and diffusion research.  Awards will be 
determined on the basis of scientific merit, program relevance, 
dissemination potential, and availability of funds.  Special 
consideration will be given to applications that include plans to 
disseminate interventions tested in low income and ethnically diverse 

The earliest anticipated award date for this program will be September 
1, 2004. Inquiries related to this notice should be addressed to the 
NCI Program Director for the particular R01, P01, P50, U01, or U19 for 
which the supplement is being requested.  Before submitting an 
applicant, each applicant (i.e., Principal Investigator) is encouraged 
to discuss the efficacy data (e.g., effect sizes, consistency with 
prior research, relevance to target populations) supporting their 
competing supplement request from the original project with their 
respective NCI research project Program Director. 


Direct inquiries concerning the programmatic and review matters to:

Jon F. Kerner, Ph.D.
Deputy Director for Research Dissemination and Diffusion
Division of Cancer Control and Population Sciences
6130 Executive Boulevard, EPN Room 6144
Bethesda, MD 20892-0001
Rockville, MD 20852 (for courier/express service)
Telephone: 301-594-7294

Direct inquiries regarding fiscal matters should be made to:

Ms. Crystal Wolfrey
Grants Administration Branch
6120 Executive Boulevard, EPS Room 243
Bethesda, MD 20892-7150
Rockville, MD  20852 (for courier/express service) 
Telephone:  301-496-8634

Submit a signed, typewritten original of the request letter and five 
signed, single-sided photocopies, in one package to:  
Cynthia Vinson, M.P.A.
Dissemination and Diffusion Coordinator 
Division of Cancer Control and Population Sciences
National Cancer Institute 
6130 Executive Blvd., EPN Room 6146 
Bethesda, MD 20892-0001 
Rockville, MD 20852 (for express/courier service) 


Weekly TOC for this Announcement
NIH Funding Opportunities and Notices

H H S Department of Health
and Human Services

  N I H National Institutes of Health (NIH)
9000 Rockville Pike
Bethesda, Maryland 20892